Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways

Authors:

Abstract
Carbon nanomaterials face a clinical translation paradox where functional complexity conflicts with regulatory predictability. This review offers a practical roadmap for safer, more controllable, and clinically translatable carbon nanotechnologies.
Funding Information
  • China Postdoctoral Science Foundation (2024M752238)
  • China Postdoctoral Science Foundation (2025M771987)
  • China Postdoctoral Science Foundation (GZC20251341)
  • Natural Science Foundation of Sichuan Province (2025ZNSFSC1649)
  • National Natural Science Foundation of China (82401144)

This publication has 231 references indexed in Scilit: